21 January 2025

The Potential—and Pitfalls—of Psychedelic Therapies for Psychiatric Disorders

Over the past decade, interest in psychedelics—including psilocybin, LSD, and MDMA—as treatments for psychiatric disorders has grown exponentially among scientists, mental health professionals, the media, and the public.

Ana Sofia Oliveira

16 January 2025

Eavesdropping on organs: immune system controls blood sugar levels

During periods of low energy—such as intermittent fasting or exercise—immune cells step in to regulate blood sugar levels, acting as the “postman” in a previously unknown three-way conversation between the nervous, immune and hormonal systems. These findings open up new approaches for managing conditions like diabetes, obesity, and cancer.

Champalimaud Open Seminars: Carlos Minutti

Date and time:

20 January 2025 – 12:00

Location:

Champalimaud Foundation Auditorium

Description:

Conventional Dendritic Cells – Ecology, Diversity, and Functio

Carlos Minutti (Immunoregulation Lab)


Moderator: Cristina João (Myeloma Lymphoma Research Group)

 

Understanding and Harnessing Cancer Immunity: From Biology to Therapy

Host

Rita Fior, PhD, Cancer Development and Innate Immune Evasion Lab


Venue

Seminar room

15 Jan. 2025

Programme Manager - Breast Cancer Research Programme

Clinical Centre
Application Starts: 15 Jan. 2025

Program Overview

The Champalimaud Foundation Breast Cancer Research Program - is dedicated to advancing the understanding, prevention, and treatment of breast cancer. The program integrates cutting-edge research with community engagement and education to improve outcomes for those affected by breast cancer.

15 Jan. 2025

Health Data Engineer - Breast Cancer Research Programme

Clinical Centre
Application Starts: 15 Jan. 2025

Program Overview

The Breast Cancer Research Program at the Champalimaud Foundation is dedicated to advancing the understanding, prevention, and treatment of breast cancer. The program integrates cutting-edge research with community engagement and education to improve outcomes for those affected by breast cancer.

14 January 2025

Researchers uncover what drives aggressive bone cancer

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a significant impact on young people and their families as treatment can require surgery or amputation. The cancer also has the potential to spread to other organs, most commonly the lungs. Because osteosarcoma is so genomically complex, it has been challenging to identify what genetic mutations drive the disease.

Marta Amaro

Alexandra Leitão

Subscribe to Champalimaud Research
Loading
Please wait...